Education
About Us
Working with TipRanks
Follow Us
Doximity (DOCS)
NYSE:DOCS
DOCS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$22.96 - $85.21
Previous CloseN/A
Volume296.07K
Average Volume (3M)2.41M
Market Cap
$9.83B
Enterprise Value$9.97B
Total Cash (Recent Filing)$165.27M
Total Debt (Recent Filing)$12.95M
Price to Earnings (P/E)54.1
Beta1.58
Next Earnings
May 20, 2025EPS Estimate
0.27Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.00
Shares Outstanding133,502,330
10 Day Avg. Volume2,202,775
30 Day Avg. Volume2,409,944
Financial Highlights & Ratios
PEG Ratio1.09
Price to Book (P/B)N/A
Price to Sales (P/S)21.48
Price to Cash Flow (P/CF)45.30
P/FCF Ratio45.30
Enterprise Value/Market Cap1.01
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit23.46
Enterprise Value/Ebitda43.10
Forecast
1Y Price Target
$73.44Price Target Upside30.47% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering17
---
Bulls Say, Bears Say
Bulls Say
Company GrowthDoximity could grow 200-300 bps above the overall market.
Customer GrowthThe number of customers spending over $500K annually has increased, indicating strong demand for DOCS' offerings.
Market PerformanceNear term conditions are robust and should be supportive to guiding in line with the Street estimate.
Bears Say
Growth NormalizationNext year, growth is expected to normalize to about 2x the market rate, which is in line with the past 4 years, suggesting a potential slowdown compared to the current growth rate.
Regulatory DelaysMeaningful cuts to the FDA’s Office of Prescription Drug Promotion could extend the typical timeline of reviewing prescription drug advertising and promotional labeling.
Regulatory RisksMacro risks have intensified, with pharma companies contending with uncertainty around tariffs and disruptions at the FDA.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
DOCS FAQ
What was Doximity’s price range in the past 12 months?
Doximity lowest stock price was $22.96 and its highest was $85.21 in the past 12 months.
What is Doximity’s market cap?
Doximity’s market cap is $9.83B.
When is Doximity’s upcoming earnings report date?
Doximity’s upcoming earnings report date is May 20, 2025 which is in 25 days.
How were Doximity’s earnings last quarter?
Doximity released its earnings results on Feb 06, 2025. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.337 by $0.113.
Is Doximity overvalued?
According to Wall Street analysts Doximity’s price is currently Undervalued.
Does Doximity pay dividends?
Doximity does not currently pay dividends.
What is Doximity’s EPS estimate?
Doximity’s EPS estimate is 0.27.
How many shares outstanding does Doximity have?
Doximity has 133,502,330 shares outstanding.
What happened to Doximity’s price movement after its last earnings report?
Doximity reported an EPS of $0.45 in its last earnings report, beating expectations of $0.337. Following the earnings report the stock price went up 35.994%.
Which hedge fund is a major shareholder of Doximity?
Currently, no hedge funds are holding shares in DOCS
---
Doximity Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$73.44 (30.47% Upside)
$73.44 (30.47% Upside)
Blogger Sentiment
Bullish
DOCS Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 298.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $79.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 3.1%
Last 30 Days ▲ 1.4%
Last 30 Days ▲ 1.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
135.42%
12-Months-Change
Fundamentals
Return on Equity
21.24%
Trailing 12-Months
Asset Growth
17.14%
Trailing 12-Months
Company Description
Doximity
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
---
DOCS Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong performance with significant revenue and EBITDA growth, driven by high client retention and successful new product launches. However, potential challenges include dependency on integrated programs and tougher future revenue comparisons.Read More>---
DOCS Revenue Breakdown
93.00% Subscription
7.00% Other
---
DOCS Stock 12 Month Forecast
Average Price Target
$73.44
▲(30.47% Upside)
Technical Analysis
Best Analysts Covering DOCS
1 Year
1 Year Success Rate
5/16 ratings generated profit
1 Year Average Return
+12.81%
reiterated a buy rating 2 months ago
Copying Vikram Kesavabhotla's trades and holding each position for 1 Year would result in 31.25% of your transactions generating a profit, with an average return of +12.81% per trade.
---